Tian A, Meng F, Li S, Wu Y, Zhang C, Luo X
Rev Endocr Metab Disord. 2024; 25(4):805-816.
PMID: 38763958
PMC: 11294269.
DOI: 10.1007/s11154-024-09885-x.
Werner H, Laron Z
Front Endocrinol (Lausanne). 2023; 14:1291812.
PMID: 37941907
PMC: 10628706.
DOI: 10.3389/fendo.2023.1291812.
Abruzzese G, Campo Verde Arbocco F, Ferrer M, Silva A, Motta A
Adv Exp Med Biol. 2023; 1428:31-70.
PMID: 37466768
DOI: 10.1007/978-3-031-32554-0_2.
Schweizer R, Martin D, Binder G
Front Endocrinol (Lausanne). 2023; 14:1122287.
PMID: 37143735
PMC: 10153665.
DOI: 10.3389/fendo.2023.1122287.
Werner H, LeRoith D
Front Oncol. 2022; 12:1055589.
PMID: 36479090
PMC: 9720135.
DOI: 10.3389/fonc.2022.1055589.
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP.
Nagaraj K, Sarfstein R, Laron Z, Werner H
Cells. 2022; 11(20).
PMID: 36291127
PMC: 9601129.
DOI: 10.3390/cells11203260.
Hyperactivation of Wnt/β-catenin and Jak/Stat3 pathways in human and zebrafish foetal growth restriction models: Implications for pharmacological rescue.
Risato G, Celeghin R, Branas Casas R, Dinarello A, Zuppardo A, Vettori A
Front Cell Dev Biol. 2022; 10:943127.
PMID: 36051436
PMC: 9424487.
DOI: 10.3389/fcell.2022.943127.
Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action.
Sarfstein R, Nagaraj K, Parikh S, Levy C, Laron Z, Benayahu D
Cells. 2022; 11(10).
PMID: 35626664
PMC: 9139319.
DOI: 10.3390/cells11101627.
Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation.
Di Patria L, Annibalini G, Morrone A, Ferri L, Saltarelli R, Galluzzi L
Cell Mol Life Sci. 2022; 79(3):150.
PMID: 35211808
PMC: 8873121.
DOI: 10.1007/s00018-022-04180-x.
MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.
Yaron-Saminsky D, Nagaraj K, Sarfstein R, Laron Z, Pasmanik-Chor M, Werner H
Int J Mol Sci. 2021; 22(21).
PMID: 34769292
PMC: 8584665.
DOI: 10.3390/ijms222111861.
Small for Gestational Age Preterm Neonates Exhibit Defective GH/IGF1 Signaling Pathway.
Motte-Signoret E, Shankar-Aguilera S, Brailly-Tabard S, Soreze Y, Dell Orto V, Ben Ammar R
Front Pediatr. 2021; 9:711400.
PMID: 34447729
PMC: 8382944.
DOI: 10.3389/fped.2021.711400.
IGF1R, IGFALS, and IGFBP3 gene copy number variations in a group of non-syndromic Egyptian short children.
Fadel I, Ragab M, Eid O, Helmy N, El-Bassyouni H, Mazen I
J Genet Eng Biotechnol. 2021; 19(1):109.
PMID: 34322776
PMC: 8319271.
DOI: 10.1186/s43141-021-00202-6.
The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
Shibel R, Sarfstein R, Nagaraj K, Lapkina-Gendler L, Laron Z, Dixit M
Cells. 2021; 10(6).
PMID: 34204736
PMC: 8231575.
DOI: 10.3390/cells10061483.
Igf signaling couples retina growth with body growth by modulating progenitor cell division.
Becker C, Lust K, Wittbrodt J
Development. 2021; 148(7).
PMID: 33722901
PMC: 8077508.
DOI: 10.1242/dev.199133.
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.
Werner H, Sarfstein R, Nagaraj K, Laron Z
Cells. 2020; 9(11).
PMID: 33182502
PMC: 7696416.
DOI: 10.3390/cells9112446.
Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
Sarfstein R, Yeheskel A, Sinai-Livne T, Pasmanik-Chor M, Werner H
Front Endocrinol (Lausanne). 2020; 11:435.
PMID: 32733384
PMC: 7359857.
DOI: 10.3389/fendo.2020.00435.
Tumor suppressor p53 regulates insulin receptor () gene expression via direct binding to the promoter.
Sarfstein R, Werner H
Oncotarget. 2020; 11(25):2424-2437.
PMID: 32637033
PMC: 7321701.
DOI: 10.18632/oncotarget.27645.
Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients.
Sinai-Livne T, Pasmanik-Chor M, Cohen Z, Tsarfaty I, Werner H, Berger R
Oncotarget. 2020; 11(17):1515-1530.
PMID: 32391121
PMC: 7197451.
DOI: 10.18632/oncotarget.27566.
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer.
Achlaug L, Sarfstein R, Nagaraj K, Lapkina-Gendler L, Bruchim I, Dixit M
Oncotarget. 2019; 10(43):4437-4448.
PMID: 31320996
PMC: 6633887.
DOI: 10.18632/oncotarget.27055.
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways.
Werner H, Lapkina-Gendler L, Achlaug L, Nagaraj K, Somri L, Yaron-Saminsky D
Cells. 2019; 8(6).
PMID: 31208077
PMC: 6627189.
DOI: 10.3390/cells8060596.